BackAlbany Molecular Research Overview

Albany Molecular Research Cost of Revenue

Cost of Revenue analysis for AMRI.

Quarterly Cost of Revenue

$131.72M
60.21% YoY

As of Jun 30, 2017

Annual Cost of Revenue (TTM)

$530.57M
58.71% YoY

Trailing 12 months ending Jun 30, 2017

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)